DSIP Research for Chronic Pain
An evidence-based overview of research examining DSIP in the context of chronic pain. This page synthesizes findings from peer-reviewed literature.
Research Summary
German and Swiss studies documented analgesic properties of DSIP that appear distinct from opioid analgesia. The peptide modulates but does not directly activate opioid receptors and may stimulate endogenous enkephalin release. Clinical studies showed improved pain tolerance, though sample sizes were small.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Chronic Pain
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. DSIP may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.